Press & Media
Last November FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery.
Last November FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery.
FLUOPTICS receives the market authorization from FDA for FLUOBEAM® to detect parathyroid tissue in real time during surgery…
FLUOPTICS© is proud to have been chosen to participate in a report published during the “Journal de la Santé” (France 5) on December 8th, 2015
The FLUOPTICS©’s mission is to supply to surgeons real-time information to localize exactly the fluorescent marker during the surgery.
Earlier in June, Fluoptics has been pleased to receive the renowned international speakers in Paris to promote a share knowledge on latest fluorescence surgery techniques. Fluoptics would like to thank you all speakers for their great présentations.
The aim of the study was to compare 2 methods of the sentinel lymph node biopsy (SLNB) procedure in bladder cancer: we applied technetium radiocolloid (RadCol) detected by a gamma ray detection probe, and indocyanine green (ICG) detected by a near-infrared fluorescent (NIRF) camera.